MedPath

The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients

Not Applicable
Completed
Conditions
HIV Infections
Peripheral Nervous System Disease
Interventions
Registration Number
NCT00000817
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

To evaluate the separate and combined efficacy of a standardized acupuncture regimen and amitriptyline on the relief of pain due to peripheral neuropathy and on the quality of life of HIV-infected patients.

Both amitriptyline, an antidepressant, and acupuncture, a Chinese medical approach that uses needles to relieve pain, have been used successfully to reduce pain in some people. It is not known how effectively these approaches relieve or reduce pain in patients with peripheral neuropathy secondary to HIV infection.

Detailed Description

Both amitriptyline, an antidepressant, and acupuncture, a Chinese medical approach that uses needles to relieve pain, have been used successfully to reduce pain in some people. It is not known how effectively these approaches relieve or reduce pain in patients with peripheral neuropathy secondary to HIV infection.

Patients are randomized to receive either standardized point acupuncture or alternate point acupuncture treatment twice weekly for the first 6 weeks, then once weekly for the next 8 weeks, plus either oral amitriptyline or placebo daily for the entire 14 weeks. Acupuncture points are located on the lower leg. Patients are evaluated at weeks 6 and 14 and are asked to keep a daily pain diary.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
260
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Amitriptyline hydrochlorideParticipants will receive standardized or alternate point acupuncture treatment twice weekly for the first 6 weeks, then once weekly for the next 8 weeks, plus either oral amitriptyline or placebo daily for the entire 14 weeks.
1Amitriptyline hydrochloride placeboParticipants will receive standardized or alternate point acupuncture treatment twice weekly for the first 6 weeks, then once weekly for the next 8 weeks, plus either oral amitriptyline or placebo daily for the entire 14 weeks.
1Point acupunctureParticipants will receive standardized or alternate point acupuncture treatment twice weekly for the first 6 weeks, then once weekly for the next 8 weeks, plus either oral amitriptyline or placebo daily for the entire 14 weeks.
Primary Outcome Measures
NameTimeMethod
Change in quality lifeThroughout study
Change in intensity of pain as measured by the daily pain diary and the global pain relief ratingAt Weeks 6 and 14
Change in neurological statusThroughout study
Permanent discontinuation of study treatment due to treatment failureThroughout study
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (11)

Harlem AIDS Treatment Group / Harlem Hosp Ctr

🇺🇸

New York, New York, United States

Partners Research

🇺🇸

Albuquerque, New Mexico, United States

Clinical Directors Network of Region II

🇺🇸

New York, New York, United States

Comprehensive AIDS Alliance of Detroit

🇺🇸

Detroit, Michigan, United States

Denver CPCRA / Denver Public Hlth

🇺🇸

Denver, Colorado, United States

Portland Veterans Adm Med Ctr / Rsch & Education Grp

🇺🇸

Portland, Oregon, United States

Veterans Administration Med Ctr / Regional AIDS Program

🇺🇸

Washington, District of Columbia, United States

Community Consortium of San Francisco

🇺🇸

San Francisco, California, United States

North Jersey Community Research Initiative

🇺🇸

Newark, New Jersey, United States

Philadelphia FIGHT

🇺🇸

Philadelphia, Pennsylvania, United States

Baltimore Trials

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath